SYNTHESIS, SPECTRAL AND MOLECULAR CHARACTERIZATION OF SOME NOVEL 2, 5-DISUBSTITUTED-1, 3, 4–OXADIAZOLE DERIVATIVES AND EVALUATION OF IN VIVO ANTITUMOUR ACTIVITY AGAINST HT 29 CELL LINE
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2018, Vol 10, Issue 6
Abstract
Neoplasia is a type of abnormal and excessive growth of tissue. The growth of a neoplasia is uncoordinated with that of the normal surrounding tissue, and it persists growing abnormally, even if the original trigger is removed. This abnormal growth usually forms a mass. The main objective of the present research work was the synthesis, characterization and evaluation of in vivo antitumour activity of some novel 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives. The in vivo antitumour activity of synthesized compounds was evaluated by HT 29 cell line induced malignant ascites on mouse model. The apoptosis of HT 29 cells was evaluated by using Gimsa and H33342 stain and the apoptosis ratios were analysed by FCM using AnnexinV-FITC/PI staining. The present experimental data displayed that the mortality was less in all groups except in tumour control group and all the synthesized compounds AB1-AB8 (100 mg/kg) significantly increased the PILS. While 5-FU increased the life span of 97.72%, and the PILS of synthesized compounds were found to be 45.45%, 59.09%, 68.18%, 56.81%, 38.63%, 84.09%, 77.27% and 90.90%. So the Synthesized compounds AB1-AB8 at the dose of 100 mg/kg significantly improved the overall survival of all treated animals and 5-FU was not significantly differed from each other in improving the overall survival of HT-29 cells. The apoptosis ratios of synthesized compounds were found as followed: AB1=26%; AB2=37.6%; AB3=43%; AB4=29%; AB5=24.1%; AB6=59.2%; AB7=48.2%; and AB8=63% respectively, while that of the Group-II (T. control) was 6.1%. When compared with standard drug 5-FU: 66.2%, it was indicated that compound AB8>AB6>AB7>AB3 were able to significantly induce HT-29 cells apoptosis.
Authors and Affiliations
Asish Bhaumik, M. Chinna Eswaraiah, Raja Chakraborty
Keywords
Related Articles
- EP ID EP622229
- DOI 10.25004/IJPSDR.2018.100602
- Views 45
- Downloads 0
GAS CHROMATOGRAPHY METHOD OF CLEANING VALIDATION PROCESS FOR 2-PROPANOL RESIDUE DETERMINATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT
Cleaning validation is an integral operation of good manufacturing practice in pharmaceutical industry. The aim of this study was to validate simple analytical method for detection of 2-propanol residue in equipment, whi...
IN-VITRO ANTIOXIDANT ACTIVITY AND GC/MS STUDIES ON THE LEAVES OF MENTHA PIPERITA (LAMIACEAE) FROM MOROCCO
The present study was to evaluate the in vitro antioxidant activity and chemical composition of essential oil of Mentha piperita from Morocco. Mentha species from the Lamiaceae family are widely distributed in Morocco an...
PRESCRIPTION PATTERN AND THERAPEUTIC RESPONSE OF VARIOUS ANTI HYPERTENSIVE DRUGS FOR THE HYPERTENSIVE PATIENTS AT PRIVATE HOSPITALS IN TAMILNADU, INDIA
The present study was conducted in order to establish the therapeutic responses and prescription pattern of various antihypertensive agents in patients with mild, moderate and severe hypertension. Prospective and compara...
CONTRIBUTION OF NMR SPECTROSCOPY, MASS SPECTROMETRY AND X-RAY DIFFRACTOMETRY TECHNIQUES TO THE CHARACTERIZATION OF 2-CHLORO-8-METHYL-3-FORMYLQUINOLINE
Quinoline and its analogues have been known to possess diverse pharmacological activities. In the last three decades 2-chloro-8-methyl-3-formylquinoline has been utilized as building blocks for the development of various...
OPTIMIZATION AND VALIDATION OF MODULATED RELEASE FORMULATION OF RANITIDINE HCL BY RESPONSE SURFACE METHODOLOGY
The objective of the present study was, 1) to systematically device a model of factors that would yield an optimized sustained release dosage form of model drug (Ranitidine HCl), 2) to validate the models using R2 v...